Partha Mitra

785 total citations
20 papers, 542 citations indexed

About

Partha Mitra is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Partha Mitra has authored 20 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Partha Mitra's work include Genomics and Chromatin Dynamics (9 papers), Epigenetics and DNA Methylation (6 papers) and Ubiquitin and proteasome pathways (6 papers). Partha Mitra is often cited by papers focused on Genomics and Chromatin Dynamics (9 papers), Epigenetics and DNA Methylation (6 papers) and Ubiquitin and proteasome pathways (6 papers). Partha Mitra collaborates with scholars based in Australia, United States and Macao. Partha Mitra's co-authors include André J. van Wijnen, Janet L. Stein, Thomas J. Gonda, Gary S. Stein, Gary S. Stein, Robert G. Ramsay, J. Wade Harper, Ricardo Medina, Sayyed K. Zaidi and William F. Holmes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Partha Mitra

20 papers receiving 534 citations

Peers

Countries citing papers authored by Partha Mitra

Since Specialization

Citations

This map shows the geographic impact of Partha Mitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Partha Mitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Partha Mitra more than expected).

Fields of papers citing papers by Partha Mitra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Partha Mitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Partha Mitra. The network helps show where Partha Mitra may publish in the future.

Co-authorship network of co-authors of Partha Mitra

This figure shows the co-authorship network connecting the top 25 collaborators of Partha Mitra. A scholar is included among the top collaborators of Partha Mitra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Partha Mitra. Partha Mitra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting transcription factors in cancer drug discovery 2020 ·SHILAP Revista de lepidopterología ·Partha Mitra	4
2	The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein 2019 ·Scientific Reports ·Lu Cao, Partha Mitra, Thomas J. Gonda	9
3	MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells 2019 ·Oncogene ·(unknown), Devathri Nanayakkara, Murugan Kalimutho, Partha Mitra, Kum Kum Khanna, Eloïse Dray, Thomas J. Gonda	20
4	Transcription regulation of MYB: a potential and novel therapeutic target in cancer 2018 ·Annals of Translational Medicine ·Partha Mitra	29
5	Flavopiridol Inhibits TGF-β-Stimulated Biglycan Synthesis by Blocking Linker Region Phosphorylation and Nuclear Translocation of Smad2 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Muhamad Ashraf Rostam, (unknown), Danielle Kamato, Partha Mitra, Terrence J. Piva, Robel Getachew, Yingnan Cao, Wenhua Zheng, Narin Osman, Peter J. Little	24
6	Gaq proteins: molecular pharmacology and therapeutic potential 2016 ·Cellular and Molecular Life Sciences ·Danielle Kamato, Partha Mitra, Felicity M. Davis, Narin Osman, (unknown), Peter J. Cabot, Rizwana Afroz, Walter G. Thomas, Wenhua Zheng, Harveen Kaur, Margaret A. Brimble, Peter J. Little	44
7	CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition ofMYBandMCL-1expression 2016 ·Oncotarget ·Partha Mitra, (unknown), James Sutton, Robert G. Ramsay, Thomas J. Gonda	38
8	Pathogenicity of Leishmania donovani is associated with the high expression of a group low molecular weight proteins 2015 ·Tropical parasitology ·Partha Mitra	4
9	Rectovaginal Fistula of Different Etiologies: Clinical Case Reports 2014 ·Nepal Journal of Obstetrics and Gynaecology ·Partha Mitra, Sanjay Mukherjee, (unknown), (unknown), (unknown), (unknown)	2
10	Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene 2012 ·Nucleic Acids Research ·Partha Mitra, Lloyd Pereira, Yvette Drabsch, Robert G. Ramsay, Thomas J. Gonda	41
11	Drug discovery in tuberculosis: a molecular approach. 2012 ·PubMed ·Partha Mitra	11
12	CDK inhibitors selectively diminish cell cycle controlled activation of the histone H4 gene promoter by p220^NPAT and HiNF‐P 2009 ·Journal of Cellular Physiology ·Partha Mitra, Prachi N. Ghule, Margaretha van der Deen, Ricardo Medina, (unknown), William F. Holmes, Xin Ye, Keiichi I. Nakayama, J. Wade Harper, Janet L. Stein, Gary S. Stein, André J. van Wijnen	13
13	The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles 2009 ·Proceedings of the National Academy of Sciences ·Ronglin Xie, Ricardo Medina, Ying Zhang, Sadiq Hussain, (unknown), Prachi N. Ghule, (unknown), Marilyn L. Keeler, Lijun Liu, Margaretha van der Deen, Partha Mitra, Jane B. Lian, Jaime A. Rivera‐Pérez, Stephen N. Jones, Janet L. Stein, André J. van Wijnen, Gary S. Stein	30
14	Transcriptional activation of the histone nuclear factor P (HiNF-P) gene by HiNF-P and its cyclin E/CDK2 responsive co-factor p220NPAT defines a novel autoregulatory loop at the G1/S phase transition 2007 ·Gene ·(unknown), (unknown), Partha Mitra, Janet L. Stein, André J. van Wijnen, Gary S. Stein	9
15	HiNF‐P is a bifunctional regulator of cell cycle controlled histone H4 gene transcription 2006 ·Journal of Cellular Biochemistry ·Partha Mitra, Ronglin Xie, J. Wade Harper, Janet L. Stein, Gary S. Stein, André J. van Wijnen	13
16	Coordinate Control and Selective Expression of the Full Complement of Replication-dependent Histone H4 Genes in Normal and Cancer Cells 2005 ·Journal of Biological Chemistry ·William F. Holmes, Corey Braastad, Partha Mitra, Christiane S. Hampe, Detlef Doenecke, Werner Albig, Janet L. Stein, André J. van Wijnen, Gary S. Stein	45
17	HiNF-P Directly Links the Cyclin E/CDK2/p220 ^NPAT Pathway to Histone H4 Gene Regulation at the G ₁ /S Phase Cell Cycle Transition 2005 ·Molecular and Cellular Biology ·(unknown), Corey Braastad, William F. Holmes, Partha Mitra, Ricardo Medina, Ronglin Xie, Sayyed K. Zaidi, Xin Ye, Wei Yue, J. Wade Harper, André J. van Wijnen, Janet L. Stein, Gary S. Stein	86
18	Maintenance of Open Chromatin and Selective Genomic Occupancy at the Cell Cycle-Regulated Histone H4 Promoter during Differentiation of HL-60 Promyelocytic Leukemia Cells 2003 ·Molecular and Cellular Biology ·Hayk Hovhannisyan, Brian C. Cho, Partha Mitra, Martı́n Montecino, Gary S. Stein, André J. van Wijnen, Janet L. Stein	24
19	Identification of HiNF-P, a Key Activator of Cell Cycle-Controlled Histone H4 Genes at the Onset of S Phase 2003 ·Molecular and Cellular Biology ·Partha Mitra, (unknown), Ricardo Medina, Hayk Hovhannisyan, Sayyed K. Zaidi, Wei Yue, J. Wade Harper, Janet L. Stein, André J. van Wijnen, Gary S. Stein	60
20	Purification and Functional Analysis of a Novel Leucine-Zipper/Nucleotide-Fold Protein, BZAP45, Stimulating Cell Cycle Regulated Histone H4 Gene Transcription 2001 ·Biochemistry ·Partha Mitra, Patricia S. Vaughan, Janet L. Stein, Gary S. Stein, André J. van Wijnen	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact